BioVenture VoiCes with Chris Garabedian · 18 May 2026
At the source: BiotechTV ↗ · audio
He describes his well-rounded background of studying and working in both software in Silicon Valley and Medicine in Boston, and the start of GV. He describes a conservative start to investing at GV, but also today how Alphabet's scale and cash gives them the ability to ride cycles and make concentrated bets on companies the team has conviction on.
As published with the episode at BioVenture VoiCes with Chris Garabedian ↗
No summary of this episode yet.